Table 2.
A | B | C | D | E | F | G | H | I | J | K | L | M | |
1 | 20* | 20* | 75%* | ||||||||||
2 | x = patient weight (kg) | y = days/admission | z = census adjustment Factor | ||||||||||
3 | Formulas | =(E3*$G$1)/C3 | =H3*G3*$K$1 | =K3*($J$1/30)*$L$1 | MAX(0,(J3-L3)/I3) | ||||||||
4 | Category | Medication | Ref Product | Units | Input Dose* | Units | Products used/day | Estimated Use* | Qty consumed per admission for (y) days | Inventory* | Use Per Month* | Use for (X) days with Global Census Adjustment | [Surge Capacity over (x) days with Census Factor (z)] |
5 | CARDIAC MEDICATIONS | Epinephrine | 1 | mg | 0.05 | mcg/kg/min | 1.4 | 25% | 7 | 2750 | 2500 | 1250 | 208 |
6 | Norepinephrine | 4 | mg | 0.05 | mcg/kg/min | 0.4 | 15% | 1 | 100 | 65 | 33 | 63 | |
7 | Vasopressin | 20 | units | 0.5 | milliunits/kg/min | 0.7 | 5% | 1 | 195 | 91 | 45 | 208 | |
8 | Phenylephrine | 10 | mg | 0.5 | mcg/kg/min | 1.4 | 10% | 3 | 447 | 102 | 51 | 138 | |
9 | Alprostadil | 500 | mcg | 0.05 | mcg/kg/min | 2.9 | 1% | 1 | 80 | 43 | 22 | 102 | |
10 | Amiodarone | 150 | mg | 5 | mcg/kg/min | 1.0 | 5% | 1 | 259 | 207 | 104 | 162 | |
11 | Atropine | 1 | mg | 0.02 | mg/kg ONCE | 0.4 | 1% | 0 | 60 | 95 | 47 | 159 | |
12 | Clevidipine | 50 | mg | 2 | mcg/kg/min | 1.2 | 10% | 2 | 175 | 280 | 140 | 15 | |
13 | Esmolol | 2000 | mg | 100 | mcg/kg/min | 1.4 | 5% | 1 | 136 | 39 | 20 | 81 | |
14 | Lidocaine | 50 | mg | 20 | mcg/kg/min | 11.5 | 5% | 12 | 1369 | 1209 | 605 | 66 | |
15 | Sodium Bicarbonate | 50 | mEq | 1 | mEq/kg 3x/day | 1.2 | 20% | 5 | 534 | 319 | 160 | 78 |
*Input variables
Column M (Surge capacity) was automatically highlighted in for <25 patinets, for 25-100 patients and for >100 patients.